These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8416152)
1. Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Selby JV; Friedman GD; Quesenberry CP; Weiss NS Ann Intern Med; 1993 Jan; 118(1):1-6. PubMed ID: 8416152 [TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy. Scheitel SM; Ahlquist DA; Wollan PC; Hagen PT; Silverstein MD Mayo Clin Proc; 1999 Dec; 74(12):1207-13. PubMed ID: 10593348 [TBL] [Abstract][Full Text] [Related]
3. A case-control study to evaluate efficacy of screening for faecal occult blood. Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161 [TBL] [Abstract][Full Text] [Related]
4. Reducing colorectal cancer mortality by repeated faecal occult blood test: a nested case-control study. Bertario L; Russo A; Crosignani P; Sala P; Spinelli P; Pizzetti P; Andreola S; Berrino F Eur J Cancer; 1999 Jun; 35(6):973-7. PubMed ID: 10533481 [TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. Mandel JS; Church TR; Ederer F; Bond JH J Natl Cancer Inst; 1999 Mar; 91(5):434-7. PubMed ID: 10070942 [TBL] [Abstract][Full Text] [Related]
6. Effect of faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy. Zappa M; Castiglione G; Grazzini G; Falini P; Giorgi D; Paci E; Ciatto S Int J Cancer; 1997 Oct; 73(2):208-10. PubMed ID: 9335444 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of repeated screening using the fecal occult blood test and its impact on reducing false-negative cancer cases. Nishida H; Urano S Eur J Cancer Prev; 2011 May; 20(3):184-9. PubMed ID: 21301345 [TBL] [Abstract][Full Text] [Related]
8. Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba. Decker KM; Nugent Z; Lambert P; Biswanger N; Singh H PLoS One; 2018; 13(9):e0203321. PubMed ID: 30180176 [TBL] [Abstract][Full Text] [Related]
9. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M; J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571 [TBL] [Abstract][Full Text] [Related]
10. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province. Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773 [TBL] [Abstract][Full Text] [Related]
11. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer. Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330 [TBL] [Abstract][Full Text] [Related]
12. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study. Saito H; Soma Y; Koeda J; Wada T; Kawaguchi H; Sobue T; Aisawa T; Yoshida Y Int J Cancer; 1995 May; 61(4):465-9. PubMed ID: 7759151 [TBL] [Abstract][Full Text] [Related]
13. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349 [TBL] [Abstract][Full Text] [Related]
14. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test. Saito H; Soma Y; Nakajima M; Koeda J; Kawaguchi H; Kakizaki R; Chiba R; Aisawa T; Munakata A Oncol Rep; 2000; 7(4):815-9. PubMed ID: 10854550 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Sonnenberg A; Delcò F; Inadomi JM Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584 [TBL] [Abstract][Full Text] [Related]
16. Long-term mortality after screening for colorectal cancer. Shaukat A; Mongin SJ; Geisser MS; Lederle FA; Bond JH; Mandel JS; Church TR N Engl J Med; 2013 Sep; 369(12):1106-14. PubMed ID: 24047060 [TBL] [Abstract][Full Text] [Related]
17. Fecal occult blood testing for colorectal cancer. Can we afford to do this? Ahlquist DA Gastroenterol Clin North Am; 1997 Mar; 26(1):41-55. PubMed ID: 9119439 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening. Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305 [TBL] [Abstract][Full Text] [Related]